Mission Bay Capital
Mission Bay Capital is a venture capital firm based in the United States, focused on supporting the entrepreneurial efforts of scientists. They provide early-stage funding and operate from facilities that include an incubator to support startups right from the initial stages. Their co-working labs allow startups to begin operations quickly, helping them tackle major challenges like chronic diseases and environmental issues. They leverage a network of advisors, industry partners, and co-investors to support the growth of startups. The team is led by notable figures like Douglas Crawford, PhD, and Robert Blazej, PhD, who have extensive experience in both the scientific and business domains. The firm distinguishes itself by emphasizing early-stage innovations and facilitating efficient operations for startups through their facilities and network.
Mission Bay Capital focuses its investments primarily in the life sciences sector. They are known for taking on early-stage investments and providing vital resources for companies at a critical time. Their geographical focus is North America, supporting primarily Series A stage companies. They have formed strategic partnerships through their incubator, MBC BioLabs, which provides state-of-the-art facilities for young companies to conduct experiments. The firm manages fund vehicles like BioInnovation Capital, but specific financial details or AUM were not disclosed on the site.
Notable investments by Mission Bay Capital include Alector, Atreca, Cell Design Labs, iPierian, Mitokinin, and Redwood Biosciences. These companies have achieved significant milestones, including successful exits, and have made advancements in various medical and biotechnology areas. Their involvement with these companies underscores their commitment to fostering groundbreaking scientific innovations that address critical needs in the life sciences sector.
Mission BioCapital
Mission BioCapital is a venture capital firm based in Cambridge, Massachusetts, founded in 2009. The firm is composed of scientists, investors, founders, and serial entrepreneurs with a focus on empowering life science entrepreneurs. They provide early-stage capital and support through a shared labs model, offering lab space and mentorship to accelerate the development of scientific solutions.
The firm primarily invests in the life sciences and biotechnology sectors, focusing on early-stage companies. They typically invest up to $500K per company and offer additional services through their Platinum Program. Mission BioCapital invests in the United States and Europe, with a portfolio that includes companies like Alector, Pandion, and Mitokinin. They are currently investing out of their fifth fund, Mission BioCapital V LP, with an AUM of $275 million.
Notable investments by Mission BioCapital include Alector - a biotechnology company, Pandion - a drug discovery firm, Mitokinin - a biotech company, Nocion Therapeutics - focused on drug discovery, and QurAlis - a biotech firm. These investments highlight their commitment to advancing life sciences and biotechnology innovations.
Mission One Capital
Mission One Capital is a venture capital firm based in Miami, Florida, United States. Founded by Kiel Berry, who has a background in Wall Street and entertainment, the firm is known for its action-driven approach to venture funding. The team is small, consisting of 1-10 members, and is committed to supporting founders with a performance mindset, providing high-velocity support to help them succeed.
The firm invests in early-stage startups, particularly at the Pre-seed and Seed stages, focusing on sectors like energy, industrial resilience, and frontier industries. Their geographical focus spans the US, Canada, and Europe. Mission One Capital typically writes checks ranging from $100K to $500K. They emphasize investments in areas that drive breakthroughs in energy and industrial resilience, aligning with their mission to fuel the next industrial revolution.
Notable investments include early stakes in companies like Lyft, Robinhood, and Impossible Foods, showcasing their interest in frontier-tech startups tackling climate, resource depletion, and inequality. These investments reflect their commitment to impact metrics tied to business and community programs.
Mission Street Capital
Mission Street Capital is a venture capital firm based in San Francisco, co-founded by Surabhi Todi and Lisa Shmulyan. The firm was established with the unique strategy of investing in AI-native startups emerging from hacker houses and talent clusters. Todi and Shmulyan's backgrounds are embedded in the hacker house culture, having met at Mission Control, a renowned hacker community. What sets them apart is their diligence process, where scouts spend extensive time living and interacting with prospective founders to assess their potential before making an investment decision. Mission Street Capital aims to be the first institutional check for companies, offering deep engagement beyond the usual pitch deck evaluation process.
The firm targets pre-seed and seed stage investments, focusing primarily on AI-driven companies originating from hacker houses globally. It writes small checks consistent with its debut sub-$2 million fund, aptly named 'Fund 0'. Despite its small size, the fund boasts a notable LP base including researchers from leading AI labs like OpenAI and investors from top-tier VC firms, underscoring its strategic value. The firm operates largely within the San Francisco Bay Area but maintains a global scouting reach through its connections with various talent clusters.
Mission Street Capital has invested in a dozen companies, with highlighted investments including Aside, an AI browser; HydraDB, an infrastructure for AI agents; Smallest AI, a voice AI company; Bild AI, a tool for construction estimation; Clera; and Ruvo, which facilitates Brazil-US money transfers. These engagements reflect the firm’s focus on AI-native businesses. The portfolio underlines its commitment to being the earliest backer leveraging its AI and tech-centric LP network for further opportunities and growth.
MissionOG
MissionOG is a venture capital firm based in Philadelphia, Pennsylvania, founded in 2012. The firm is led by a team of experienced operators and investors, including Andy Newcomb and Gene Lockhart. With a team of 34 professionals, MissionOG focuses on partnering with high-growth B2B companies that are driving the digitization of the economy. They pride themselves on their deep operational knowledge and commitment to supporting entrepreneurs.
MissionOG invests primarily in fintech, data, and AI-driven technologies, with a typical check size ranging from $5 million to $10 million. They focus on early and growth-stage investments, particularly in Series A rounds, and have a strong presence in the United States. The firm manages several funds, including the MissionOG Fund and MissionOG Fund III, with a total AUM of over $200 million.
Notable investments by MissionOG include Yardstik - business productivity software, d1g1t - financial software, Sayari - data analytics, Alternative Payments - financial software, and Autobooks - financial software. These investments highlight their focus on fintech and data-driven solutions.
Mistletoe
Mistletoe is a collective impact community that seeks to create a human-centered sustainable future using technology. A group of entrepreneurs, investors, researchers, visionaries and other people who are at the forefront of the startup community willing to tackle the major challenges facing humankind in the near future.
<br />
<br />
Our main activities are diverse, such as investment, R & D, joint ventures with startups, and construction of ecosystems. The biggest feature is the concept of "ORCHESTRATION". New discoveries and scientific reactions are created by creating a venue for different talents so that an orchestra composed of different players can produce great effects. As a result, we believe that it can have a much greater impact than tackling issues alone. Mistletoe hopes to create many movements around the world by developing this “ORCHESTRATION” with many like-minded friends.
MISUMI Ventures
MISUMI Ventures is a US-based venture capital firm established by MISUMI Group, focusing on seed-stage investments in robotics, physical AI, and advanced hardware startups. Headquartered in the San Francisco Bay Area, this fund operates with an independent GP/LP structure separated from its parent company's balance sheet. The team is led by Eddie Chen, the Managing Partner, alongside other MISUMI Americas executives involved without holding formal partner titles. The firm distinguishes itself by offering not just capital but also the access to an extensive network of factories and sourcing partners.
The firm targets seed-stage investment with a flexibility for pre-seed and Series A rounds. It focuses on sectors including robotics, physical AI, factory automation, industrial AI, supply-chain intelligence, generative design, and oppportunistic investments in aerospace, climate tech, and medical devices. Their initial check size ranges from $0.5M to $1.5M, with MISUMI Group as the sole LP. The firm leverages the parent company's manufacturing capabilities to add value beyond financial investments.
MISUMI Ventures has yet to announce its investment portfolio, as the first check is planned to be deployed by the end of 2026. The firm's strategic plan is to co-invest alongside established Silicon Valley VCs, allowing it to benefit from experienced leadership in deals. The fund's focus on ties with manufacturing capabilities presents a unique proposition not common among other seed investors.
Mita Ventures
MITA Ventures combines a venture fund with a strategic mentoring program— drawing on our deep network in Silicon Valley -for technology companies from Mexico, as well as fostering the expansion of US and Latin American companies into the Mexico market. Based in San Francisco, CA and Punta Mita, Mexico, MITA works to foster cross-cultural opportunities in technology, and responds to the demand for identifying opportunities and funding investments in Mexico.
Mithril Capital
Mithril Capital is a venture capital firm founded in 2012 by Ajay Royan and Peter Thiel. Based in Austin, Texas, they focus on building long-term partnerships with teams using technology to innovate and build lasting companies. The firm emphasizes a sector and geography-agnostic investment strategy, aiming to drive change in industries overdue for transformation.
Mithril invests across various sectors without specific exclusions, partnering with companies at various stages of their development. Their overall approach includes evaluating diverse opportunities for potential long-term impact and value creation. The firm was founded with a vision to leverage innovative solutions across multiple industries, often challenging established norms and practices.
Notable investments from Mithril Capital include companies that have used technology to enhance productivity and innovation. These portfolio companies reflect Mithril's philosophy of investing in transformative technology-led initiatives, although specific company names and detailed descriptions are not provided on their site.
Mitsubishi UFJ Capital
Mitsubishi UFJ Capital (“MUCAP”) was founded in 1974 as one of the first venture capital firms in Japan. Backed by Mitsubishi UFJ Financial Group, the leading financing group headquartered in Tokyo, Japan, MUCAP have been helping entrepreneurs in Japan, and around the world. More than 870 companies we worked together with have gone public.
Mitsubishi UFJ Capital (MUCAP) backs start-ups throughout their stages of development, from the seed / early stage, through the middle stage, to the later stage where an initial public offering (IPO) or a M&A comes into view.
We have been investing in innovative business ideas that anticipate societal needs, and engaged in commercializing the research results of universities and other academia, to name just a few. Through these endeavors, we have been working hand in hand with our start-up investees from an early stage in their business development.
Our role goes beyond just investment. Once our start-up investees are on track, we help take their business to the next level, by facilitating business partnerships with large companies to expand sales channels, providing advice on organizational enhancements with an eye to an IPO, and offering assistance in various other ways. We tailor our support to the needs of start-ups in varying stages of development.
Our investees span many spheres, from manufacturing and consumer goods to cutting-edge domains including artificial intelligence (AI), the internet of things (IoT), financial technology (Fintech) and other technologies, software as a service (SaaS), and life sciences. We have proactively been investing in supporting emerging industries without bias toward particular sectors.
What is essential to these activities is our team-based approach as one team. For each investee, a team is formed consisting of: an investment professional, or “capitalist,” who works shoulder to shoulder with the start-up; a business strategy partner who has extensive expertise; and personnel helping forge business partnerships with large companies. The team makes a concerted effort to increase the value of the start-up.
We have capitalists stationed in Osaka and Nagoya, as well as in our head office in Tokyo. Leveraging these resources, we strive to work even more closely with start-ups located not only in Tokyo but throughout the country.
History and track record
MUCAP is a venture capital firm founded in 1974. Our approach to start-ups remains unchanged since the founding: we first share their aspirations of entrepreneurs, establish trust as a capital partner, and then assist throughout their growth stages. This is what we were founded for, and we continue committed to our mission.
Looking back at our business over the decades, while Japan’s venture capital market has experienced some significant ups and downs, MUCAP has consistently supplied growth capital as part of MUFG .
This has resulted in our strong track record. Just for the period since 2005, the year in which the current MUCAP was created, we have made a cumulative total of more than 1,000 investments, aggregating in excess of \50 billion.
Collaboration with MUFG companies
Our support is not limited to helping start-ups reach an IPO. To make MUFG’s comprehensive financial capabilities available to start-ups, we work closely with MUFG Bank, Mitsubishi UFJ Trust and Banking, Mitsubishi UFJ Morgan Stanley Securities, and other Group companies. Even after start-ups are listed on stock exchange, our clients continue to be provided with broad financial services that they deserve as the Group’s valued customers. Specifically, our professionals offer optimal financial services from those offered by MUFG companies, in an effort to contribute to their sustained growth.